Aquinox Pharmaceuticals Alternatives & Competitors

12 companies similar to Aquinox Pharmaceuticals — Discovering and developing small molecule therapeutics to treat cancer and infla...

Synta Pharmaceuticals

Innovating patient care with advanced small molecule therapies for severe medical conditio...

Post-IPO Equity $217.35M

Biotechnology Health Care +1

858 Therapeutics

Discovering innovative small molecule therapeutics for the treatment of cancer

30 Venture round $105.23M

San Diego, United States

Biotechnology Health Care +1

Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health

Post-IPO Equity $101.50M

Biotechnology Health Care +1

InflaRx

Controlling Inflammation - developing drugs to treat life threatening and chronic inflamma...

46 Post-IPO Equity $250.20M

Jena, Germany

Health Care Health and Wellness +1

Track all Aquinox Pharmaceuticals competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

ProteoTech

Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996

2-10 Venture round $10.54M

Biotechnology Health Care

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

Kintor Pharmaceutical Limited

We are committed to developing the best therapeutics to improve human health.

29 Series D $99.00M

China

Biopharma Biotechnology +3

Incyclix Bio

Regaining Cell Cycle Control

13 Series B $64.00M

Durham, United States

Biotechnology Health Care +2

Tyligand Bioscience

Innovative small molecule therapeutics for cancer and autoimmune disease treatment.

4 Series A

Biotechnology Health Care

IpiNovyx Bio

We are a drug platform focused on treating autoimmune and inflammatory diseases.

6 Seed $10.00M

United States

Biopharma Biotechnology +1

NeoPhore Ltd

Discovering drugs that create neoantigens

18 Series B $33.80M

Cambridge, United Kingdom

Biotechnology Health and Wellness

CGI Pharmaceuticals, Inc.

11 Series C $44.30M

Branford, United States

Biotechnology Health Care +1

About Aquinox Pharmaceuticals

Aquinox Pharmaceuticals Inc. is a Vancouver-based pharmaceutical company that has been dedicated to discovering and developing small molecule therapeutics since its establishment in 2004. With a focus on treating cancer and inflammatory diseases, the company's product portfolio includes AQX-MN100, a medication designed...

Business keywords

Pharmaceuticals, Small Molecule Therapeutics, Cancer Treatment, Inflammatory Disease Treatment, AQX-MN100, SH2-containing Inositol 5'-phosphatase Inhibition Program, Drug Development, Bio-pharmaceuticals, Cancer Therapy, Blood Cell Recovery, Vancouver, Canada

Frequently Asked Questions

Companies similar to Aquinox Pharmaceuticals include Synta Pharmaceuticals, 858 Therapeutics, Anthera Pharmaceuticals, InflaRx, ProteoTech. They work in Biotechnology and Health Care and share Aquinox Pharmaceuticals's focus on pharmaceuticals, drug development and small molecule therapeutics.

Bounce Watch lists 12 companies that share Aquinox Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Aquinox Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Aquinox Pharmaceuticals Profile Synta Pharmaceuticals Alternatives 858 Therapeutics Alternatives Anthera Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Aquinox Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.